Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Shares Issued (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Shares Issued for 16 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Issued rose 75.38% to $2.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.8 million, a 6.61% increase, with the full-year FY2025 number at $6.8 million, up 6.61% from a year prior.
  • Shares Issued was $2.2 million for Q4 2025 at Lemaitre Vascular, up from $1.6 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $59.5 million in Q3 2021 to a low of $164000.0 in Q2 2022.
  • A 5-year average of $4.5 million and a median of $1.4 million in 2021 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: skyrocketed 5020.84% in 2021, then plummeted 98.31% in 2022.
  • Lemaitre Vascular's Shares Issued stood at $1.7 million in 2021, then rose by 6.69% to $1.8 million in 2022, then plummeted by 38.61% to $1.1 million in 2023, then increased by 12.58% to $1.2 million in 2024, then surged by 75.38% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Shares Issued are $2.2 million (Q4 2025), $1.6 million (Q3 2025), and $1.8 million (Q2 2025).